688428 诺诚健华
已收盘 08-16 15:00:00
资讯
新帖
简况
诺诚健华-U08月16日主力资金流出116万元 连续3日减仓
自选股智能写手 · 08-16 15:18
诺诚健华-U08月16日主力资金流出116万元 连续3日减仓
诺诚健华（688428）8月13日主力资金净买入15.75万元
证券之星 · 08-14
诺诚健华（688428）8月13日主力资金净买入15.75万元
诺诚健华：业绩说明会定于8月21日举行
每日经济新闻 · 08-13
诺诚健华：业绩说明会定于8月21日举行
诺诚健华-U08月12日获主力加仓717万元 环比增加807.59%
自选股智能写手 · 08-12
诺诚健华-U08月12日获主力加仓717万元 环比增加807.59%
诺诚健华（688428）8月9日主力资金净买入165.62万元
证券之星 · 08-10
诺诚健华（688428）8月9日主力资金净买入165.62万元
诺诚健华-U08月05日遭主力抛售211万元 环比增加151.19%
自选股智能写手 · 08-05
诺诚健华-U08月05日遭主力抛售211万元 环比增加151.19%
诺诚健华-U08月02日主力资金流出84万元 连续3日减仓
自选股智能写手 · 08-02
诺诚健华-U08月02日主力资金流出84万元 连续3日减仓
诺诚健华-U08月01日遭主力抛售181万元 环比增加123.46%
自选股智能写手 · 08-01
诺诚健华-U08月01日遭主力抛售181万元 环比增加123.46%
【港股异动 | 生物医药股集体走强 创新药优化审批方案发布 行业有望迎来加速发展】智通财经APP获悉，生物医药股集体走强，截至发稿，药明合联(02268.
智通财经 · 07-31
【港股异动 | 生物医药股集体走强 创新药优化审批方案发布 行业有望迎来加速发展】智通财经APP获悉，生物医药股集体走强，截至发稿，药明合联(02268.
诺诚健华(09969)上涨5.08%，报4.55元/股
金融界 · 07-31
诺诚健华(09969)上涨5.08%，报4.55元/股
诺诚健华盘中异动 早盘快速上涨5.08%报4.550港元
自选股智能写手 · 07-31
诺诚健华盘中异动 早盘快速上涨5.08%报4.550港元
【诺诚健华(09969.HK)创新药 ICP-332 在美国完成首例受试者给药】智通财经APP讯，诺诚健华(09969.HK)公布，公司于近日获悉，公司创新药 ICP-332 在美国完成首例受试者给药。
智通财经 · 07-24
【诺诚健华(09969.HK)创新药 ICP-332 在美国完成首例受试者给药】智通财经APP讯，诺诚健华(09969.HK)公布，公司于近日获悉，公司创新药 ICP-332 在美国完成首例受试者给药。
诺诚健华(09969)创新药 ICP-332 在美国完成首例受试者给药
智通财经 · 07-24
诺诚健华(09969)创新药 ICP-332 在美国完成首例受试者给药
【诺诚健华：ICP-332在美国完成首例受试者给药】诺诚健华(688428)7月24日晚间公告，公司创新药ICP-332在美国完成首例受试者给药。
东方财富网 · 07-24
【诺诚健华：ICP-332在美国完成首例受试者给药】诺诚健华(688428)7月24日晚间公告，公司创新药ICP-332在美国完成首例受试者给药。
【诺诚健华(688428.SH)：创新药ICP-332在美国完成首例受试者给药】智通财经APP讯，诺诚健华(688428.
智通财经 · 07-24
【诺诚健华(688428.SH)：创新药ICP-332在美国完成首例受试者给药】智通财经APP讯，诺诚健华(688428.
诺诚健华(688428.SH)：创新药ICP-332在美国完成首例受试者给药
智通财经 · 07-24
诺诚健华(688428.SH)：创新药ICP-332在美国完成首例受试者给药
诺诚健华-U07月23日主力资金流出294万元 连续3日减仓
自选股智能写手 · 07-23
诺诚健华-U07月23日主力资金流出294万元 连续3日减仓
Vivo Capital减持诺诚健华：或套现1.88亿港元 仍是重要股东
雷递网 · 07-20
Vivo Capital减持诺诚健华：或套现1.88亿港元 仍是重要股东
【诺诚健华(09969.HK)股东Fund VIII、Opp Fund等合计减持4016.9万股公司股份 持股比例降至 4.
智通财经 · 07-19
【诺诚健华(09969.HK)股东Fund VIII、Opp Fund等合计减持4016.9万股公司股份 持股比例降至 4.
诺诚健华(09969)股东Fund VIII、Opp Fund等合计减持4016.9万股公司股份 持股比例降至 4.82%
智通财经 · 07-19
诺诚健华(09969)股东Fund VIII、Opp Fund等合计减持4016.9万股公司股份 持股比例降至 4.82%
公司概况
公司名称：
诺诚健华医药有限公司
所属行业：
医药制造业
上市日期：
2022-09-21
主营业务：
诺诚健华医药有限公司的主营业务为创新药的研发、生产及商业化。主要产品为奥布替尼、ICP-192、ICP-723、ICP-332、ICP-189、ICP-490、Tafasitamab、ICP-105、ICP-033、ICP-488、ICP-248、ICP-B03、ICP-915、ICP-B02等。公司获得奖项为中国技术创业协会科技创新贡献奖、北京市“专精特新”中小企业、中国新经济企业500强等。
发行价格：
11.03
{"stockData":{"symbol":"688428","market":"SH","secType":"STK","nameCN":"诺诚健华","latestPrice":9.85,"timestamp":1723791600000,"preClose":9.87,"halted":0,"volume":2200080,"delay":0,"floatShares":258000000,"shares":1764000000,"eps":-0.4316,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.02,"latestTime":"08-16 15:00:00","open":9.85,"high":10.02,"low":9.76,"amount":21777100,"amplitude":0.0263,"askPrice":9.86,"askSize":8,"bidPrice":9.85,"bidSize":27,"shortable":0,"etf":0,"ttmEps":-0.4316,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724031000000},"adr":0,"adjPreClose":9.87,"symbolType":"stock_kcb","openAndCloseTimeList":[[1723771800000,1723779000000],[1723784400000,1723791600000]],"highLimit":10.86,"lowLimit":8.88,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1764217202,"pbRate":2.47,"roa":"--","roe":"--","epsLYR":-0.37,"committee":-0.699436,"marketValue":17378000000,"floatMarketCap":2545000000,"peRate":-22.822057,"changeRate":-0.002,"turnoverRate":0.0085,"status":1,"afterMarket":{"amount":0,"volume":0,"close":9.85,"buyVolume":0,"sellVolume":33077,"time":1723793637153,"indexStatus":"已收盘 08-16 15:30:00","preClose":9.87}},"requestUrl":"/m/hq/s/688428/wiki","defaultTab":"wiki","newsList":[{"id":"2459269706","title":"诺诚健华-U08月16日主力资金流出116万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2459269706","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459269706?lang=zh_cn&edition=full","pubTime":"2024-08-16 15:18","pubTimestamp":1723792705,"startTime":"0","endTime":"0","summary":"08月16日, 诺诚健华-U股价跌0.20%，报收9.85元，成交金额2177万元，换手率0.85%，振幅2.63%，量比0.56。诺诚健华-U今日主力资金净流出116万元，连续3日净流出，上一交易日主力净流出270万元，今日环比减少57.04%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为42.86%，平均跌幅为1.64%。该股近5个交易日上涨2.39%，主力资金累计净流入173万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出1085万元，其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816152932959dcb29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816152932959dcb29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688428"],"gpt_icon":0},{"id":"2459319163","title":"诺诚健华（688428）8月13日主力资金净买入15.75万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459319163","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459319163?lang=zh_cn&edition=full","pubTime":"2024-08-14 08:23","pubTimestamp":1723595010,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月13日收盘，诺诚健华报收于9.82元，下跌1.01%，换手率0.93%，成交量2.41万手，成交额2373.08万元。近5日资金流向一览见下表：诺诚健华融资融券信息显示，融资方面，当日融资买入49.54万元，融资偿还59.63万元，融资净偿还10.08万元。诺诚健华主营业务：创新药的研发、生产及商业化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081400015174.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688428","BK1574","BK1161","09969"],"gpt_icon":0},{"id":"2459727920","title":"诺诚健华：业绩说明会定于8月21日举行","url":"https://stock-news.laohu8.com/highlight/detail?id=2459727920","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459727920?lang=zh_cn&edition=full","pubTime":"2024-08-13 18:09","pubTimestamp":1723543771,"startTime":"0","endTime":"0","summary":"每经AI快讯，诺诚健华 8月13日晚间发布公告称，公司2024年半年度业绩说明会定于2024年8月21日上午11:00-12:00，以上证路演中心网络互动的形式进行。出席本次业绩说明会的人员有：董事会主席兼行政总裁JisongCui，独立非执行董事胡兰，首席财务官傅欣，信息披露境内代表袁蓓。2023年1至12月份，诺诚健华的营业收入构成为：医药制造业占比99.79%。截至发稿，诺诚健华市值为173亿元。道达号“个股趋势”提醒：1. 近30日内无机构对诺诚健华-U进行调研。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408131809499f271daf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408131809499f271daf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688428"],"gpt_icon":0},{"id":"2458478678","title":"诺诚健华-U08月12日获主力加仓717万元 环比增加807.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458478678","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458478678?lang=zh_cn&edition=full","pubTime":"2024-08-12 15:19","pubTimestamp":1723447167,"startTime":"0","endTime":"0","summary":"08月12日, 诺诚健华-U股价涨3.12%，报收9.92元，成交金额5755万元，换手率2.26%，振幅4.57%，量比1.85。诺诚健华-U今日主力资金净流入717万元，连续3日净流入，上一交易日主力净流入79万元，今日环比增加807.59%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为27.27%，平均涨幅为0.64%。该股近5个交易日上涨8.89%，主力资金累计净流入935万元；近20日主力资金累计净流出839万元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408121534039f23ade8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408121534039f23ade8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688428","BK0239"],"gpt_icon":0},{"id":"2458526025","title":"诺诚健华（688428）8月9日主力资金净买入165.62万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458526025","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458526025?lang=zh_cn&edition=full","pubTime":"2024-08-10 08:11","pubTimestamp":1723248716,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月9日收盘，诺诚健华报收于9.62元，上涨2.45%，换手率1.94%，成交量5.0万手，成交额4790.21万元。近5日资金流向一览见下表：诺诚健华融资融券信息显示，融资方面，当日融资买入127.37万元，融资偿还163.29万元，融资净偿还35.92万元。诺诚健华主营业务：创新药的研发、生产及商业化。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081000012607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688428","09969","BK0239","BK1161","BK1574"],"gpt_icon":0},{"id":"2457712940","title":"诺诚健华-U08月05日遭主力抛售211万元 环比增加151.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457712940","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457712940?lang=zh_cn&edition=full","pubTime":"2024-08-05 15:19","pubTimestamp":1722842357,"startTime":"0","endTime":"0","summary":"08月05日, 诺诚健华-U股价跌0.76%，报收9.11元，成交金额2777万元，换手率1.17%，振幅2.72%，量比1.10。诺诚健华-U今日主力资金净流出211万元，连续4日净流出，上一交易日主力净流出84万元，今日环比增加151.19%。该股近5个交易日上涨3.88%，主力资金累计净流出517万元；近20日主力资金累计净流出1245万元，其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408051539389f0f802f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408051539389f0f802f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688428"],"gpt_icon":0},{"id":"2456150427","title":"诺诚健华-U08月02日主力资金流出84万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2456150427","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456150427?lang=zh_cn&edition=full","pubTime":"2024-08-02 15:18","pubTimestamp":1722583135,"startTime":"0","endTime":"0","summary":"08月02日, 诺诚健华-U股价跌0.97%，报收9.18元，成交金额3899万元，换手率1.60%，振幅5.29%，量比1.66。诺诚健华-U今日主力资金净流出84万元，连续3日净流出，上一交易日主力净流出181万元，今日环比减少53.59%。该股近5个交易日上涨2.34%，主力资金累计净流出432万元；近20日主力资金累计净流出1436万元，其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408021531359f07f309&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408021531359f07f309&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688428"],"gpt_icon":0},{"id":"2456176639","title":"诺诚健华-U08月01日遭主力抛售181万元 环比增加123.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456176639","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456176639?lang=zh_cn&edition=full","pubTime":"2024-08-01 15:19","pubTimestamp":1722496798,"startTime":"0","endTime":"0","summary":"08月01日, 诺诚健华-U股价涨0.76%，报收9.27元，成交金额2747万元，换手率1.15%，振幅2.28%，量比1.19。诺诚健华-U今日主力资金净流出181万元，上一交易日主力净流出81万元，今日环比增加123.46%。该股近5个交易日上涨3.00%，主力资金累计净流出558万元；近20日主力资金累计净流出1333万元，其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408011535329573e363&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408011535329573e363&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688428"],"gpt_icon":0},{"id":"2455923635","title":"【港股异动 | 生物医药股集体走强 创新药优化审批方案发布 行业有望迎来加速发展】智通财经APP获悉，生物医药股集体走强，截至发稿，药明合联(02268.","url":"https://stock-news.laohu8.com/highlight/detail?id=2455923635","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455923635?lang=zh_cn&edition=full","pubTime":"2024-07-31 11:48","pubTimestamp":1722397725,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0823426480.USD","688428","LU0326950275.SGD","LU0819121731.USD","688331","LU1242518931.SGD","09995","LU0856984785.SGD","159992","LU0516422952.EUR","09969","LU0588546209.SGD","LU0456827905.SGD","LU0516423091.SGD","LU0708995583.HKD","LU0572944931.SGD","SG9999002562.SGD","LU1064131003.USD","BK1610","06990","161726","LU0516422440.USD","LU1720050803.USD","LU0039217434.USD","LU0456846285.SGD","LU1969619763.USD","LU0307460666.USD","BK1576","06978","LU0043850808.USD","LU0327786744.USD","BK1574","LU0348735423.USD","LU2328871848.SGD","IE00B0JY6N72.USD","02268","02269","LU2039709279.SGD","LU0196878994.USD","LU0359202008.SGD","LU1880383366.USD","LU0417516902.SGD","LU1242518857.USD","399441","LU0140636845.USD","LU1688375341.USD","BK1583","LU0348825331.USD","LU0516422366.SGD"],"gpt_icon":0},{"id":"2455119942","title":"诺诚健华(09969)上涨5.08%，报4.55元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2455119942","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455119942?lang=zh_cn&edition=full","pubTime":"2024-07-31 10:44","pubTimestamp":1722393885,"startTime":"0","endTime":"0","summary":"7月31日，诺诚健华(09969)盘中上涨5.08%，截至10:44，报4.55元/股，成交564.52万元。诺诚健华医药有限公司是一家拥有一体化生物医药平台的领先企业，主要从事研发治疗癌症和自身免疫性疾病的创新药物。公司具备强大的内部研发能力和世界级管理团队，同时拥有均衡的管线组合和针对经过验证或新颖生物通路的候选药物。截至2024年一季报，诺诚健华营业总收入1.66亿元、净利润-1.42亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/31104441921091.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["688428","BK1574","09969","BK1161","BK0239"],"gpt_icon":0},{"id":"2455232944","title":"诺诚健华盘中异动 早盘快速上涨5.08%报4.550港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455232944","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455232944?lang=zh_cn&edition=full","pubTime":"2024-07-31 10:44","pubTimestamp":1722393878,"startTime":"0","endTime":"0","summary":"2024年07月31日早盘10时44分，诺诚健华股票出现异动，股价大幅上涨5.08%。截至发稿，该股报4.550港元/股，成交量126.4万股，换手率0.08%，振幅5.54%。资金方面，该股资金流入372.488万港元，流出144.083万港元。诺诚健华股票所在的生物技术行业中，整体涨幅为1.64%。其相关个股中，科笛-B、药明生物、药明合联涨幅较大，振幅较大的相关个股有华康生物医学、方达控股、博安生物，振幅分别为14.08%、14.08%、11.64%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731104439941fc5a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731104439941fc5a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","688428","BK0239"],"gpt_icon":0},{"id":"2453945003","title":"【诺诚健华(09969.HK)创新药 ICP-332 在美国完成首例受试者给药】智通财经APP讯，诺诚健华(09969.HK)公布，公司于近日获悉，公司创新药 ICP-332 在美国完成首例受试者给药。","url":"https://stock-news.laohu8.com/highlight/detail?id=2453945003","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453945003?lang=zh_cn&edition=full","pubTime":"2024-07-24 19:32","pubTimestamp":1721820749,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["159992","BK6512","09969","06978","688428","5I4.SI","BK1574","BK0239","BK1161","BK6004"],"gpt_icon":0},{"id":"2453003949","title":"诺诚健华(09969)创新药 ICP-332 在美国完成首例受试者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2453003949","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453003949?lang=zh_cn&edition=full","pubTime":"2024-07-24 19:32","pubTimestamp":1721820749,"startTime":"0","endTime":"0","summary":"智通财经APP讯，诺诚健华 公布，公司于近日获悉，公司创新药 ICP-332 在美国完成首例受试者给药。据悉，ICP-332 是公司自主研发的具有全球知识产权的 1 类创新药，是高效、高选择性的新型口服 TYK2 抑制剂。ICP-332 在中国开展的治疗中重度特应性皮炎的 II 期临床研究达到多个有效性终点，展示了卓越的疗效和安全性。ICP-332 在与治疗 AD 患者不同类别/作用机制疗法的对比中显示了更好的疗效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1155172.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","09969","06978","BK1574","688428","BK0239","159992"],"gpt_icon":0},{"id":"2453714900","title":"【诺诚健华：ICP-332在美国完成首例受试者给药】诺诚健华(688428)7月24日晚间公告，公司创新药ICP-332在美国完成首例受试者给药。","url":"https://stock-news.laohu8.com/highlight/detail?id=2453714900","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453714900?lang=zh_cn&edition=full","pubTime":"2024-07-24 17:54","pubTimestamp":1721814854,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wap.eastmoney.com/a/202407243139085651.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_eastmoney","symbols":["688428","09969","159992","BK6004","5I4.SI","BK6512","BK1161","BK0239","06978","BK1574"],"gpt_icon":0},{"id":"2453107671","title":"【诺诚健华(688428.SH)：创新药ICP-332在美国完成首例受试者给药】智通财经APP讯，诺诚健华(688428.","url":"https://stock-news.laohu8.com/highlight/detail?id=2453107671","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453107671?lang=zh_cn&edition=full","pubTime":"2024-07-24 17:37","pubTimestamp":1721813830,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06978","BK6004","5I4.SI","BK0239","159992","BK1574","09969","BK6512","BK1161","688428"],"gpt_icon":0},{"id":"2453076723","title":"诺诚健华(688428.SH)：创新药ICP-332在美国完成首例受试者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2453076723","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453076723?lang=zh_cn&edition=full","pubTime":"2024-07-24 17:37","pubTimestamp":1721813830,"startTime":"0","endTime":"0","summary":"智通财经APP讯，诺诚健华(688428.SH)发布公告，公司于近日获悉，公司创新药ICP-332在美国完成首例受试者给药。ICP-332是公司自主研发的具有全球知识产权的1类创新药，是高效、高选择性的新型口服TYK2抑制剂。TYK2是一种非受体酪氨酸激酶，属于Janus激酶(JAK)家族，是JAK-STAT信号通道上一个重要激酶，在T细胞炎症发病机制上起到重要作用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1155031.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","06978","688428","159992","BK1574","BK1161","09969"],"gpt_icon":0},{"id":"2453702176","title":"诺诚健华-U07月23日主力资金流出294万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2453702176","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453702176?lang=zh_cn&edition=full","pubTime":"2024-07-23 15:19","pubTimestamp":1721719191,"startTime":"0","endTime":"0","summary":"07月23日, 诺诚健华-U股价跌3.30%，报收8.80元，成交金额3428万元，换手率1.49%，振幅4.29%，量比0.92。诺诚健华-U今日主力资金净流出294万元，连续3日净流出，上一交易日主力净流出163万元，今日环比增加80.37%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为40.91%，平均跌幅为1.43%。该股近5个交易日下跌4.14%，主力资金累计净流出627万元；近20日主力资金累计净流出1656万元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407231541569552484d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407231541569552484d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688428"],"gpt_icon":0},{"id":"2452616932","title":"Vivo Capital减持诺诚健华：或套现1.88亿港元 仍是重要股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2452616932","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452616932?lang=zh_cn&edition=full","pubTime":"2024-07-20 20:24","pubTimestamp":1721478242,"startTime":"0","endTime":"0","summary":"雷递网 雷建平 7月20日诺诚健华医药有限公司日前发布公告，宣布重要股东Vivo Capital进行减持，减持了诺诚健华2.27%股权。此次减持后，Fund VIII持股为4.24%，Surplus Fund VIII持股为0.58%，Fund IX、Opp Fund、Asia Opp Fund、Co-Invest Fund均不再持股。截至昨日收盘，诺诚健华股价为4.71港元，市值为83.09亿港元。若以收盘价计算，Vivo Capital可能套现1.88亿港元。诺诚健华2024年第一季度营收为1.66亿元，同比下降12.44%；净亏损为1.42亿元，扣非后净亏损为1.34亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407202024319f719676&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407202024319f719676&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","688428","09969"],"gpt_icon":0},{"id":"2452681429","title":"【诺诚健华(09969.HK)股东Fund VIII、Opp Fund等合计减持4016.9万股公司股份 持股比例降至 4.","url":"https://stock-news.laohu8.com/highlight/detail?id=2452681429","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452681429?lang=zh_cn&edition=full","pubTime":"2024-07-19 18:55","pubTimestamp":1721386517,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["159938","BK1161","BK1574","BK1515","09969","BK0239","BK4184","IX","09939","688428"],"gpt_icon":0},{"id":"2452295264","title":"诺诚健华(09969)股东Fund VIII、Opp Fund等合计减持4016.9万股公司股份 持股比例降至 4.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452295264","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452295264?lang=zh_cn&edition=full","pubTime":"2024-07-19 18:55","pubTimestamp":1721386517,"startTime":"0","endTime":"0","summary":"智通财经APP讯，诺诚健华(09969)公布，公司于近日收到公司股东 Fund VIII、Surplus Fund VIII、Opp Fund、Fund IX、Asia Opp Fund、CoInvest Fund 发来的《诺诚健华医药有限公司简式权益变动报告书》。Fund VIII、Surplus Fund VIII、Opp Fund、Fund IX、Asia Opp Fund、CoInvest Fund 于2024年7月17日合计减持4016.9万股，持股数量减少至约8505.31万股，持有股份占公司已发行总股数的比例从 7.09%减少至 4.82%，不再是公司持股 5%以上的股东。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1153361.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1161","BK0239","688428","09969"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2022-09-21","address":"OgierGlobal(Cayman)Limited,89NexusWay,CamanaBay,GrandCayman,KY1-9009,CaymanIslands","stockEarnings":[{"period":"1week","weight":0.0239},{"period":"1month","weight":0.0535},{"period":"3month","weight":0.1954},{"period":"6month","weight":0.0932},{"period":"1year","weight":-0.0492},{"period":"ytd","weight":-0.1435}],"companyName":"诺诚健华医药有限公司","boardCode":"AI0027","perCapita":"--","boardName":"医药制造业","registeredCapital":"0万元","compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0282},{"period":"3month","weight":-0.0871},{"period":"6month","weight":0.0047},{"period":"1year","weight":-0.0899},{"period":"ytd","weight":-0.0321}],"survey":" 诺诚健华医药有限公司的主营业务为创新药的研发、生产及商业化。主要产品为奥布替尼、ICP-192、ICP-723、ICP-332、ICP-189、ICP-490、Tafasitamab、ICP-105、ICP-033、ICP-488、ICP-248、ICP-B03、ICP-915、ICP-B02等。公司获得奖项为中国技术创业协会科技创新贡献奖、北京市“专精特新”中小企业、中国新经济企业500强等。","serverTime":1723903133595,"listedPrice":11.03,"stockholders":"0人","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺诚健华(688428)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺诚健华(688428)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺诚健华,688428,诺诚健华股票,诺诚健华股票老虎,诺诚健华股票老虎国际,诺诚健华行情,诺诚健华股票行情,诺诚健华股价,诺诚健华股市,诺诚健华股票价格,诺诚健华股票交易,诺诚健华股票购买,诺诚健华股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺诚健华(688428)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺诚健华(688428)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}